RC

Rima Chakrabarti

Venture Partner at KdT Ventures

United States

Overview 

Rima Chakrabarti is an accomplished early-stage biotech investor and board director, currently serving as a Venture Partner at KdT Ventures. She has made significant investments in companies like Modulus Therapeutics and Remedy Robotics, showcasing her expertise in the healthcare sector and her ability to identify promising opportunities in the digital health and health IT fields.

Work Experience 

  • Co-Founder & Managing Partner

    2024 - Current

    Acting CEO of Sentinel Biotherapeutics, a RBL portfolio company

  • Venture Partner

    2024

  • Partner

    2021 - 2024

    Investment portfolio: Remedy Robotics, Dimension Inx, Cypris Materials, Modulus Therapeutics, Faeth Therapeutics, Motif Neuro

  • Principal

    2020 - 2021

KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector.

  • Adjunct Professor, Bioengineering

    2024

  • Board Member

    2022

  • Board Member

    2021

  • Advisory Board Member

    2023 - 2024

  • Adjunct Professor

    2021 - 2023

    Neuroscience teaching faculty

  • Associate Principal

    2020 - 2020

  • Entrepreneurship Fellow

    2018 - 2020

  • Resident Physician

    2017 - 2018

    Departments of Internal Medicine and Neurology

Penn Medicine is the medical school that provides medical research and education services to students.

Raised $70,900,000.00 from Warren Alpert Foundation, National Cancer Institute, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health and National Institutes of Health.

  • Research Fellow

    2013 - 2017

The Howard Hughes Medical Institute, a non-profit medical research organization, aims to advance biomedical research and science education.

Raised $1,000,000.00 from Salt Lake Community College.

Articles About Rima

Relevant Websites